E

Emergent Biosolutions

D
EBS
USD
1.74
(18.75%)
Market Closed
165,075.00
Volume
1.5
EPS
-
Div Yield
-0.980392
P/E
583,030,996.48
Market Cap
Today
19.9129%
1 Week
21.499%
1 Month
19.783%
6 Months
149.434%
12 Months
368.936%
Year To Date
357.261%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
ICE
ICE
0.23
(0.1476%)
USD
CME
CME
0.88
(0.3979%)
USD
NDAQ
NDAQ
0.51
(0.6566%)
USD
C
CBOE
-0.95
(-0.4717%)
USD
G
GNK
0.745
(4.4358%)
USD
H
HAL
-0.955
(-3.1306%)
USD
N
NG
0.045
(1.3235%)
USD
O
OFG
-2.34
(-5.0518%)
USD

Title:
Emergent Biosolutions

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.
Do you need help or have a question?
Contact Us